Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC (CYTK), sold 4,210 shares at $58.22 ($245K) on 2025-10-21, disclosed to the SEC on 2025-10-21.
Scheduled sale ($245k) by EVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.22 | 2,105 | $123K | 50.0% |
| 2 | $58.22 | 2,105 | $123K | 50.0% |
| Total | $58.22 avg | 4,210 | $245K | 100% |
| Filing → |
| CYTK | SELL | 2026-09-08 | $264K | — | Filing → |
| CYTK | SELL | 2026-08-18 | $265K | — | Filing → |
| CYTK | SELL | 2026-07-23 | $282K | — | Filing → |